| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |